14/11/2022 - 11:08 Portfolio The joining of forces by Arseus Medical and Pro-Motion Medical represents a starting point for the expansion of a unique platform for orthopaedic devices in the Low Countries. Weiterlesen
07/11/2022 - 08:30 Portfolio Mit dem Erwerb von Control Mechatronics erweitert die E.GRUPPE ihr Leistungsspektrum und setzt den eingeschlagenen Wachstumskurs fort Weiterlesen
28/10/2022 - 09:00 Portfolio ProjectiveGroup erreicht den nächsten Meilenstein mit der Übernahme von Charco & Dique Weiterlesen
18/10/2022 - 07:30 Portfolio With the support of Gimv, Groupe Claire acquires E.I.E. from Sade, a subsidiary of Veolia Weiterlesen
21/09/2022 - 07:30 Portfolio Gimv partners with the founders of Les Psy Réunis group to develop a leading outpatient mental care provider in Switzerland Weiterlesen
27/07/2022 - 17:45 Finanziell Outcome of the optional dividend for the financial year 2021/2022: 53.3% of the dividend rights on the financial year 2021/2022 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 25.9 million Weiterlesen
20/07/2022 - 08:20 AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma Weiterlesen
13/07/2022 - 07:30 Portfolio Gimv transfers stake in the Eurocept group - active in "Hospital-at-home" services, outpatient clinics and specialty pharmaceuticals - to its founder Weiterlesen
12/07/2022 - 07:30 Portfolio Gimv, Lenaerts/LVR and ABN Climatization lay the foundation of a leading group of installation companies Weiterlesen
29/06/2022 - 17:45 Finanziell Report of the Annual and Special General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.60 per share in the form of an optional dividend Weiterlesen
29/06/2022 - 07:30 Finanziell Gimv - Modalités du dividende optionnel Apport du droit au dividende net en échange de la souscription d'une nouvelle action à 45,50 euros ou 25 droits au dividende relatifs à l’exercice 2021/2022 Weiterlesen
15/06/2022 - 07:30 Portfolio Gimv strengthens its position in life sciences venture capital with the creation of a new dedicated platform Weiterlesen
14/06/2022 - 13:55 ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline Weiterlesen
09/06/2022 - 07:30 Portfolio Gimv takes a significant interest in Picot, an industrial group active in the production of gates & fencing and provider of fencing solutions Weiterlesen
07/06/2022 - 07:30 Portfolio Gimv co-leads CHF 71M (USD 74M) Series B financing in ImmunOs Therapeutics to develop novel therapies in oncology and autoimmune disease. Weiterlesen
25/05/2022 - 17:00 Finanziell Convocation of the annual general meeting of Gimv on June 29th, 2022 Weiterlesen
24/05/2022 - 07:30 Portfolio Gimv investiert erneut in Industrieautomatisierung und wird Mehrheitseigner des Werkstückträgerspezialisten Variotech Weiterlesen
19/05/2022 - 06:58 Finanziell Beeindruckende Wachstumsleistung unserer Portfolio-Unternehmen führt zu starkem Ergebnis Weiterlesen
18/05/2022 - 07:25 Portfolio Gimv invests in Variass, a specialized developer and producer of electronic and mechatronic products and systems Weiterlesen
26/04/2022 - 08:15 Portfolio Die KÖBERL Group wächst weiter mit dem Erwerb von KRIOTEC und erweitert ihr Leistungsspektrum um Kühl-, Kälte- und Klimatechnik Weiterlesen
22/04/2022 - 07:00 Portfolio Gimv invests in BioConnection, a contract development and manufacturing organisation for injectable (bio)pharmaceutical products Weiterlesen
07/04/2022 - 07:30 Portfolio Gimv announces the creation of Olyn group, leader in omnichannel customer engagement Weiterlesen
